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Abstract:  Rhodococcus  equi is  an  uncommon  Gram  positive,  variably  acid
appears  as  hard  to  treat  mostly  owing  to  the  establishment  of  intracellular  niches.  Lack  of 
interpretive  criteria  for  susceptibility  testing  may lead  to  under
resistances, whereas knowledge about this pathogen’s clinical impact may be affected by erroneous 
phenotype-based characterization at a genus and species level.
We present the case of a bacteraemia with a concomitant lung mass in a lymphoma patient, that 
further highlights the emergence of rhodococcal diseases as a matter for concern in the fields of 
infectious diseases and haematology.
Introduction: Rhodococcus  equi
organism  that  has  been  collected  from  soil,  water, 
horses,  cattle,  swines  and  wild  birds;  although  it  is 
found in stools of many grazing animals, foals show a 
unique susceptibility to clinical disease. They usually 
present  with  a  subacute  to  chronic  purulent 
bronchopneumonia,  complicating  with  abscess 
formation and suppurative involvment of distant sites 
including colon, lymph nodes and skin. 
rarely  affects  other herbivores, but  may  cause  swine 
granulomatous  submaxillary  and  subma
lymphadenitis.  In  humans,  it  is  responsible  for  rare, 
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is  an  uncommon  Gram  positive,  variably  acid
appears  as  hard  to  treat  mostly  owing  to  the  establishment  of  intracellular  niches.  Lack  of 
interpretive  criteria  for  susceptibility  testing  may lead  to  under-reporting  or  overestimation  of 
esistances, whereas knowledge about this pathogen’s clinical impact may be affected by erroneous 
based characterization at a genus and species level.
We present the case of a bacteraemia with a concomitant lung mass in a lymphoma patient, that 
rther highlights the emergence of rhodococcal diseases as a matter for concern in the fields of 
infectious diseases and haematology.
is  a  zoonotic 
has  been  collected  from  soil,  water, 
horses,  cattle,  swines  and  wild  birds;  although  it  is 
found in stools of many grazing animals, foals show a 
unique susceptibility to clinical disease. They usually 
chronic  purulent 
bronchopneumonia,  complicating  with  abscess 
formation and suppurative involvment of distant sites 
including colon, lymph nodes and skin. The organism 
rarely  affects  other herbivores, but  may  cause  swine 
granulomatous  submaxillary  and  submandibolary 
lymphadenitis.  In  humans,  it  is  responsible  for  rare, 
potentially fatal  diseases, predominantly occurring in 
compromised  patients  with  neutropenia,  underlying 
HIV infection,  lymphoma,  T
leukaemia,  chronic  and  acute  myeloid/chr
acute  lymphoblastic  leukemia,  chronic  renal  failure, 
end  stage  liver  disease,  lung  cancer,  alcoholism, 
diabetes  mellitus,  along  with  those  undergoing 
splenectomy,  or  receiving  corticosteroids  and/or 
immunosuppressive drugs (i.e. for rheumatoid ar
sarcoidosis,  systemic  lupus  erythematosus  and 
antineutrophil  cytoplasmic  antibodies  positive 
vasculitis),  solid  organ  transplantation  (kidney, 
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is  an  uncommon  Gram  positive,  variably  acid-fast  pathogen,  that 
appears  as  hard  to  treat  mostly  owing  to  the  establishment  of  intracellular  niches.  Lack  of 
reporting  or  overestimation  of 
esistances, whereas knowledge about this pathogen’s clinical impact may be affected by erroneous 
We present the case of a bacteraemia with a concomitant lung mass in a lymphoma patient, that 
rther highlights the emergence of rhodococcal diseases as a matter for concern in the fields of 
potentially fatal  diseases, predominantly occurring in 
compromised  patients  with  neutropenia,  underlying 
infection,  lymphoma,  T-cell  prolymphocytic 
leukaemia,  chronic  and  acute  myeloid/chronic  and 
acute  lymphoblastic  leukemia,  chronic  renal  failure, 
end  stage  liver  disease,  lung  cancer,  alcoholism, 
diabetes  mellitus,  along  with  those  undergoing 
splenectomy,  or  receiving  corticosteroids  and/or 
immunosuppressive drugs (i.e. for rheumatoid arthritis, 
sarcoidosis,  systemic  lupus  erythematosus  and 
antineutrophil  cytoplasmic  antibodies  positive 
vasculitis),  solid  organ  transplantation  (kidney, Mediterr J Hematol Infect Dis 2011, 3; Open Journal System
pancreas,  kidney-pancreas,  heart,  liver,  lung)  and 
HSCT  (Hematopoietic  Stem  Cell  Transplantation). 
Conversely, only 10-15% of all cases happens in the 
apparent absence of any immune system impairment. 
Mortality  of  about  11%,  50-55%,  and  20-25%  is 
observed  in  immunocompetent  people,  AIDS 
(Acquired Immune Deficiency Syndrome) patients, and 
compromised  hosts  without  HIV  infection, 
respectively.
1-8
Case  report:  A  54-year-old  male  patient  suffering 
from  refractory  non-Hodgkin  lymphoma with 
peripheral  B  lymphocytes,  LLC  type  (diagnosed  6 
years  before),  was  admitted  to  the  Haematology 
department of the  Pescara  Civic  Hospital  due to  the 
onset  of  fever  (up  to  39°C).  Blood  samples  (two 
bioMérieux  BacT/Alert  aerobe  bottles  plus  one  for 
anaerobe organisms) were taken for culture; a second 
set (for only aerobes) was sent to laboratory 30 min 
later, then meropenem was started, without success. 
After  48  h  incubation,  the  aerobe  samples  were 
detected as positive by the instrument. Smear staining 
showed  Gram  positive  coccobacilli,  with  cultures 
growing  R.  equi-like colonies  (see  below)  on  sheep 
blood agar (> 200 colony-forming units [CFU]/plate), 
after  72  h  incubation,  in  ambient  air,  at  37
oC. 
BioMérieux  Vitek2  identified  the  isolate  as  Kocuria 
kristinae (excellent  identification,  99%  certainty); 
anyway,  Kocuria species are  known  to  only  include 
cocci, not coccobacilli; so, 16S RNA sequencing was 
performed and finally confirmed the isolate as R. equi, 
as expected.
8,9
A  Clinical  and  Laboratory  Standards  Institute 
(CLSI) disc diffusion assay
10 was performed, with the 
isolate  showing  resistance  to  penicillin,  oxacillin, 
clindamycin and tetracycline, and susceptibility to all 
among  erythromycin,  ciprofloxacin,  cotrimoxazole, 
rifampin, teicoplanin and vancomycin. Notably, due to 
the  lack  of  specific  inhibition  zone  diameter 
breakpoints, interpretive criteria for staphylococci were 
used. Again, being resistance mechanisms still unclear, 
the  strain  was  prudently  considered  as  sharing  PBP 
(Penicillin  Binding Protein)  mutation  with  oxacillin-
resistant  staphylococci,  then  pan-β-lactam  resistant. 
Meropenem was then replaced by vancomycin (10-day 
administration), which led to resolution of fever within 
48  h.  Blood  cultures  performed  after  1  week  from 
starting glycopeptide did not grow any organisms. 
The patient did not have any central venous lines, 
and was receiving no chemotherapies at the time that 
the  bacteraemic  episode  was  diagnosed.  Of  interest, 
stool  and  sputum  cultures  grew  R.  equi,  both 
concurrently  with  bacteraemia  and  after  the  patient 
recovered from the latter; this was perhaps due to the 
intracellular  survival  of  the  organism,  so  that 
vancomycin could not eradicate colonization. Notably, 
a cavitated left upper lobe lung nodule (Figure 1) was 
observed at  CT  (Computed Tomography) scan  and 
surgically removed, after resolution of the bloodstream 
infection.  The  omogenated  tissue  grew  R.  equi as  a 
pure  culture  (>10
5 CFU/ml),  with  all  among  blood, 
lung,  stool  and  sputum  isolates  sharing  the  same 
behaviour towards drugs (genome comparison was not 
performed, unfortunately). Then, we wondered whether 
the organism moved from lung to blood, or vice versa. 
Finally, in spite of the well known diffusion of R. equi
in livestock, the patient did not refer any contact with 
animals,  so that the  source of  colonization  remained 
unknown.
Figure 1. Patient’s lung nodule at CT scan.
Discussion: Rhodococci are Gram positive organisms 
belonging  to  the  group  of  mycolata  (mycolic  acid 
containing bacteria), that also incorporates the genera 
Nocardia, Gordonia, Corynebacterium, Tsukamurella, 
Dietzia,  Williamsia,  Turicella,  Skermania, and 
Mycobacterium.
11 The name Rhodococcus was firstly 
used by the German botanist Wilhelm Friedrich Zopf 
in 1891, when classifying pigment-producing bacterial 
and  fungal  microorganisms.  The  genus  was  then 
redefined  in  1977  to  include  members  of  the 
rhodochrous complex,  which contained nocardioform 
and  mycobacterial-like  species.  R.  equi (previously 
Corynebacterium  equi)  appears  as  an  encapsulated, 
non-motile,  catalase-positive,  CAMP  test-positive, 
strictly aerobe, pleomorphic coccobacillus (cells can be 
erroneously labeled as belonging to corynebacteria and 
micrococci), although rhodococci may be observed as 
cocci  on  solid  media  and  tissues,  but  appear  as 
pleomorphic  (with  long  rods  or  filaments,  mycelial 
branching and rudimentary beading) in liquid cultures. 
R.  equi grows  optimally  at  30
oC,  forming  large, Mediterr J Hematol Infect Dis 2011, 3; Open Journal System
mucoid, irregular, salmon-pink to red colonies after 2-7 
days  of  incubation  (Figure  2).  Phenotype-based 
misidentification  as  Corynebacterium  sp.  has  been 
obtained  by  using  automated  methods  for  typing. 
Finally,  acid-fast  staining  cannot  discriminate  the 
organism from mycobacteria.
7,9,12-15
Figure  2. Colonies  on  chocolate agar  plate  (image  taken  from 
Yamshchikov AV et al. Lancet Infect Dis 2010; 10: 350-359, With 
the permission of the author).
R.  equi was  firstly  isolated  from  foals  with 
pyogranulomatous  pneumonia in  1923,  with  the  first 
human  infection  being  diagnosed  in  1967;  major 
clinical  manifestations  include  lung,  liver,  kidney, 
psoas  muscle,  subcutaneous,  pelvic  and  brain 
abscesses, pneumonia (even with necrotizing cavitary 
lesions,  pulmonary  malakoplakia,  mediastinal 
lymphadenitis,  effusion/empyema,  concomitant 
bacteraemia  and  disseminated  infection),  cutaneous 
wound infections, gastrointestinal ulcerations, diarrhea, 
meningitis,  pericarditis,  endocarditis,  osteomyelitis, 
peritonitis  (associated  with  ambulatory  peritoneal 
dialysis)  and  peritoneal  shunt  infection,  cervical 
adenopathy, lymphangitis,  mastoiditis, endophtalmitis 
and  sepsis.  Clinical  picture  of  low  airway  disease 
usually  includes  cachexia,  fatigue  and  weight  loss; 
these symptoms, along with the occasional and variable 
acid fastness of the pathogen and its predilection for 
causing  upper-lobe  cavitation,  frequently  lead  to 
misdiagnosis  as  pulmonary  tuberculosis.  Due  to 
survival  inside  histiocytes,  diseases  are  commonly 
chronic  and  recurrent,  with  relapses  occurring  after 
brief  courses  of  antibiotics,  or  during  treatment.
5-
8,12,13,16,17 
In this context, malakoplakia is a dense infiltration 
of foamy histiocytes with intracellular coccobacilli and 
scattered  concentric  basophilic  inclusions  called 
Michaelis-Gutmann  bodies,  which  likely  represent 
infected macrophages with ingested bacteria; although 
not  specific  to  R.  equi infection  (Escherichia  coli, 
Pasteurella multocida and Mycobacterium tuberculosis
may  cause  similar  pathological  changes),  it  is 
frequently  associated  with  lung  illnesses  by  this 
species, in compromised hosts (Figure 3).
7 The surface 
soil  of  50-95%  of  horse  farms  shows  high 
concentrations  of the  microorganism, with  inhalation 
of infected dust particles and aerosols appearing as the 
main  route  of  transmission  to  foals.  Also,  these  can 
acquire  the  infection  through  direct  inoculation  of 
wounds  and  mucous  membranes,  as  well  as  by 
metastatic  dissemination  to  distant  sites.  Similarly, 
humans may fall ill after ingestion, inhalation or direct 
inoculation of bacteria into skin lesions. Man disease is 
in fact strongly related to livestock exposure or farming 
environments, although apparent contact with animals 
may be lacking and no clear evidence of endogenous 
colonization as a source for human illness exists so far. 
Finally,  even  if  nosocomial  and  person-to-person 
transmission is rare, pneumonia in patients sharing the 
same hospital room has been described.
7,8,12,13,16,17   
Figure  3. Lung  tissue  with  intracellular  coccobacillary  forms
(image taken from Yamshchikov AV et al. Lancet Infect Dis 2010; 
10: 350-359, With the permission of the author).
Little is still known about this pathogen’s resistance 
to  drugs;  in  vitro sensitivity  to  erythromycin, 
fluoroquinolones,  rifampin,  aminoglycosides, 
imipenem,  glycopeptides,  as  well  as  penicillin, 
erythromycin, vancomycin, rifampin and minocycline 
resistance, have been observed over the years. Also, its 
behaviour under exposure to tetracycline, clindamycin 
and cotrimoxazole may vary. Resistance is presumed to 
occur  owing  to  PBP  mutation,  increased  antibiotic 
degradation,  and  β-lactamase  production,  but  further 
studies are evoked to shed some light on this obscure 
field.  Intrinsic  along  with  acquired  resistance  to 
penicillins  and  cephalosporins  (including  loss  of 
sensitivity during therapy) have been described, so that 
the use of β-lactams is controversial and combination 
with  intracellularly  active  compounds  (such  as Mediterr J Hematol Infect Dis 2011, 3; Open Journal System
rifampin,  erythromycin,  azithromycin,  and 
ciprofloxacin)  should  be  preferred  (since 
intrahistiocytic  survival  remains  a  major  virulence 
trait). Again, the use of linezolid, as well as that of β-
lactam/β-lactamase  inhibitor  combination  has  been 
proposed.  Treatment  length  should  be  based  on 
frequent  radiographic  as  well  as  clinical  assessment, 
with  prolonged  (9-12  months)  therapy  being 
recommended in  immunosuppressed hosts; instead, a 
2- to  8-week  course  of  two  antibiotics  seems  to  be 
enough for localised diseases (such as mild-moderate 
pneumonia and soft tissue abscess). In addition, some 
published works suggest that a 2- to 6-weeks induction 
with an intravenous compound (i.e. vancomycin, or a 
carbapenem,  or  an  aminoglycoside)  is  needed  in 
compromised  patients,  then  combined  with  up  to  6 
months of oral azithromycin or rifampin. The infection 
can  be  faced  by  antibiotics  alone,  although  surgical 
treatment  may  be  beneficial  for  debulking  extensive 
disease.
4,7,8,13,16,18,19
This  brief communication may add to the current 
knowledge  about  bloodstream  and  respiratory 
infections  by  rhodococci;  also,  it  firstly  reports 
misidentification  of  R.  equi as Kocuria sp.,  thus 
emphasizing the risk of wrongly typing bacteria, unless 
genome-based  methods  are  used.  Again,  we  would 
suggest microbiologists to prolong cultures (not only 
those for fungi) up to ≥48 h, aiming to observe slowly 
growing bacteria that would be otherwise missed; but 
above all, we would increase clinicians’ awareness of 
this pathogen’s morbidity in compromised people. 
13 In 
this  context, we believe a deeper  attention shoud be 
given to uncommon nosocomial agents of infections, to 
establish  specific  criteria  for  sensitivity  testing,  to 
investigate among their mechanisms of resistance, to 
better understand the epidemiology in the environment 
and  within  hospitals,  and  to  increase  the  knowledge 
and  consciousness  of  their  clinical  impact  and 
pathogenic  traits,  that  will  otherwise  remain 
fragmentary and incomplete. 
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